Header cover image

Singaporean (SGX) Pharma Industry Analysis

UpdatedMay 30, 2023
DataAggregated Company Financials
Companies5
  • 7D-1.9%
  • 3M40.4%
  • 1Y53.1%
  • YTD59.1%

The Pharma industry has stayed flat over the last week. As for the the longer term, the industry is up 55% over the past 12 months. Looking forward, earnings are forecast to grow by 16% annually.

Industry Valuation and Performance

Has the Singaporean Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 30 May 2023S$7.1bS$1.6bS$291.8m11.7x24.3x4.6x
Thu, 27 Apr 2023S$6.0bS$1.5bS$267.8m12.9x22.6x3.9x
Sat, 25 Mar 2023S$5.4bS$1.4bS$265.0m8.8x20.3x3.9x
Mon, 20 Feb 2023S$5.8bS$1.4bS$252.0m9.7x23.2x4.2x
Wed, 18 Jan 2023S$5.1bS$1.4bS$264.8m8.7x19.2x3.6x
Fri, 16 Dec 2022S$4.9bS$1.4bS$261.2m8.2x18.7x3.6x
Sun, 13 Nov 2022S$4.9bS$1.3bS$255.8m10.8x19x3.6x
Tue, 11 Oct 2022S$4.4bS$1.3bS$247.1m10.7x17.7x3.3x
Thu, 08 Sep 2022S$4.9bS$1.4bS$249.9m10.8x19.5x3.6x
Sat, 06 Aug 2022S$4.8bS$1.3bS$228.5m10.1x20.9x3.6x
Mon, 04 Jul 2022S$5.0bS$1.3bS$229.3m10.4x21.7x3.7x
Wed, 01 Jun 2022S$4.9bS$1.3bS$228.9m10.8x21.5x3.7x
Fri, 29 Apr 2022S$4.6bS$1.3bS$232.7m12.5x19.9x3.4x
Sun, 27 Mar 2022S$5.5bS$1.4bS$248.4m12x22x3.9x
Tue, 22 Feb 2022S$5.5bS$1.4bS$219.7m14.6x24.9x4x
Thu, 20 Jan 2022S$5.7bS$1.3bS$212.7m14.9x26.7x4.2x
Sat, 18 Dec 2021S$5.3bS$1.3bS$212.4m14.1x25x4x
Mon, 15 Nov 2021S$5.4bS$1.3bS$211.9m14.8x25.3x4x
Wed, 13 Oct 2021S$5.4bS$1.3bS$203.4m14.5x26.3x4.1x
Fri, 10 Sep 2021S$5.7bS$1.3bS$203.2m22.4x28.2x4.4x
Sun, 08 Aug 2021S$5.8bS$1.3bS$203.2m20.4x28.4x4.4x
Sat, 01 May 2021S$5.5bS$1.3bS$205.8m21.6x26.8x4.3x
Tue, 02 Feb 2021S$4.5bS$1.3bS$218.6m16.7x20.4x3.5x
Fri, 06 Nov 2020S$3.9bS$1.3bS$210.7m16.8x18.4x3.1x
Mon, 10 Aug 2020S$4.1bS$1.3bS$239.9m20.4x17.3x3.3x
Price to Earnings Ratio

13.7x


Total Market Cap: S$3.9bTotal Earnings: S$283.4mTotal Revenue: S$1.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Singaporean Pharma Industry Price to Earnings3Y Average 21.9x202120222023
Current Industry PE
  • Investors are optimistic on the Singaporean Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 24.5x which is higher than its 3-year average PE of 21.9x.
  • The 3-year average PS ratio of 3.8x is lower than the industry's current PS ratio of 4.6x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 5.7% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Singaporean Healthcare industry?

SG Market-0.86%
Healthcare-1.46%
Pharma-1.95%
Pharma-1.95%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
42C iX BiopharmaS$0.0954.4%
+S$3.1m
-46.0%PS19.5x
BFK Pharmesis InternationalS$0.144.3%
+S$165.6k
68.6%PS0.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

H02

S$9.30

Haw Par

7D

-0.1%

1Y

-20.6%

1J5

S$0.28

Hyphens Pharma International

7D

-3.4%

1Y

-3.4%

T14

US$2.25

Tianjin Pharmaceutical Da Ren Tang Group

7D

-3.0%

1Y

116.3%

BFK

S$0.14

Pharmesis International

7D

4.3%

1Y

68.6%

42C

S$0.095

iX Biopharma

7D

4.4%

1Y

-46.0%